AI / data analytics / healthtech / informatics

Molecules
#AI #AI / data analytics / healthtech / informatics #Compounds #Drug discovery #Library screening

The evolution of chemical collections and drug-like diversity 

Andrea Altieri, Chief Scientific Officer, and Diana Zelencova-Gopejenko, Chief Executive Officer, Molport, explore how curated compound libraries—and the platforms that support them—are transforming the landscape of modern screening campaigns in drug discovery.  The development of screening libraries has closely followed advances in medicinal chemistry, computational methods, and molecular biology. In… Read More

#Exclusive Content

Genomics concept
#AI / data analytics / healthtech / informatics #Drug discovery #eBook #Multi-omics

eBook: Omics-driven drug discovery

A new eBook is now available for download for free from DDW and Evotec. One of the givens of modern medicine is that a more profound understanding of the molecular complexity of disease processes will lead to more precise, personalised treatment options. Multiomics, integrating multiple types of data from… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #eBook #Multi-omics

Omics-driven drug discovery

One of the givens of modern medicine is that a more profound understanding of the molecular complexity of disease processes will lead to more precise, personalised treatment options. Multiomics, integrating multiple types of data from an individual participant’s biological sample, can provide a more holistic view of the molecular factors… Read More

#eBooks #Resources

#AI / data analytics / healthtech / informatics #Drug development #Drug discovery #Generative AI

From knowledge to creation: keeping up with AI 

Generative AI is now rapidly disrupting entire industries and new technology breakthroughs are emerging at pace. As new iterations push the boundaries of deep research and insight generation, the implications for life sciences are both profound and uncertain. Reflecting on the rapid progression of GenAI, and its potential to propel… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Chromatography #Drug discovery

How data standards are revolutionising chromatography data workflows

Burkhard Schaefer, Managing Director of Splashlake, explores how chromatography is being impacted by emerging data standards. In drug discovery, every inefficiency in experimental workflows costs time, money, and the chance to bring life-saving treatments to patients. Chromatography has long been hampered by data silos, proprietary formats, and disconnected instrumentation. But… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #DMTA #Drug discovery

AI-augmented innovation: Enabling DMTA with digital-physical synergy

Andrew Anderson, Vice President, Innovation and Informatics Strategy at ACD/Labs, looks at how AI is enabling true drug design. Innovators in the pharma and biopharma sectors are actively seeking systems that accelerate the discovery, development, and commercialisation of new products. Of particular interest are systems to support the implementation of… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Drug discovery #Non-animal model (NAM) #Organ-on-a-chip #Preclinical development

What comes after animal models?  

Mariana Argenziano, Associate Director Manufacturing Technologies, and Jeroen de Groot, Divisional Chief Executive Officer at Ncardia, explore how human-relevant preclinical research can move the industry past its reliance on animal models.   In April 2025, the US Food and Drug Administration (FDA) released a roadmap to reducing animal testing in preclinical… Read More

#Exclusive Content

Artificial intelligence
#AI / data analytics / healthtech / informatics #Antibodies #Antibody-based therapeutics #Artificial intelligence (AI) #Clinical trial design #Clinical trials #Start-ups

New podcast: Innovative applications of AI in drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovative applications of AI in drug discovery”, which covers two articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “Decoding diseases: The AI renaissance in clinical trials” and “Advancing antibody… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug development #ICON #Public health

ICON on the real-world integration of AI in drug R&D

DDW’s Megan Thomas speaks with ICON's IT Director, Marco Heldoorn, about leveraging artificial intelligence (AI) to enhance efficiency, decision-making, and patient outcomes across the drug development lifecycle, from early feasibility to post-marketing. MT: Could you provide an overview of your findings when it comes to drug development and AI? TO:… Read More

#Business & Investment #Exclusive Content

#AI / data analytics / healthtech / informatics #Alzheimer's #CNS #Gene editing #Human disease models #Interview #Neurodegenerative disorders #Neurology #Neuropsychiatric disorders #Neuroscience #Precision medicine #PrecisionLife #Stem cells

Podcast: Unlocking neuroscience drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovative uses for biomarkers in drug discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “Advances in neuroscience drug discovery”, “Putting human data at the centre of… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cancer #Drug development #Drug discovery

Insilico Medicine study validates ENPP1 as immune checkpoint for cancers  

Biotechnology company Insilico Medicine has unveiled a new study showcasing how the company’s advanced generative AI platform and integrated workflow helped to identify and validate ENPP1 as a critical immune checkpoint among multiple solid tumours, which helped to the development of a highly specific oral ENPP1 inhibitor, ISM5939. Read More

#News

#AI / data analytics / healthtech / informatics #Cancer research #Drug discovery #Emulate #Gene expression #Gene therapy #Interview #Metabolomics #Multi-omics #Next generation sequencing #NGS #Omics #Organ-on-a-chip #Personalised medicine #Preclinical investigations #Spatial biology

Podcast: Cutting-edge tools shaping early-stage drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Cutting-edge tools shaping early-stage drug discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “The use-case for NGS”, “Are organ-chips the future of preclinical… Read More

#News

Artificial intelligence
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Lab technology

The real impact of AI on molecular design

Martin Stumpe, PhD, Chief Data & Artificial Intelligence Officer at Danaher, examines the factors affecting AI’s impact on drug discovery. The artificial intelligence (AI) boom in life sciences has sparked a rush of new technologies to design molecules fit for purpose. The potential is enormous, with promised benefits for both… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Biotech #DDW Turning Science into Business Summit #Drug discovery

Register now: Learn to navigate AI-driven drug discovery

Hosted by Drug Discovery World and sponsored by The Jackson Laboratory, register now for the DDW ‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery, to learn about the areas of opportunity for AI & ML in the drug discovery sector. Taking place on 30 April,… Read More

#News

Machine learning concept
#AI / data analytics / healthtech / informatics #Biotech #DDW Turning Science into Business Summit #Drug discovery

Webinar: Navigating AI-driven drug discovery

Hosted by Drug Discovery World and sponsored by The Jackson Laboratory, register now for the DDW ‘Turning Science into Business’ AI & ML summit: Navigating AI-driven drug discovery, to learn about the areas of opportunity for AI & ML in the drug discovery sector. Taking place on 30 April,… Read More

#News

Meet The Exhibitor
#AI / data analytics / healthtech / informatics #Antibodies #Cancer research #Career #From the top #Genetics / genomics #Interview #Meet the Researcher #Oncology #Research and development #Sitting Down With #Women in STEM

New podcast: Getting to know key drug discovery leaders

This is the latest episode of the free DDW narrated podcast, titled “Getting to know key drug discovery leaders”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Sitting down with… Neil Dhawan”, “Meet the researcher: Giusy Di Conza, iOnctura”… Read More

#News